Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/25/2007US20070248610 Endothelial growth factor specific immunoglobulin for use in preventing tumor proliferation; anticancer treatments
10/25/2007US20070248609 Therapeutic Method
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248607 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248605 Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248603 Immunoglobulin fusion with enhanced affinity for Fc gamma RIIa; tissue targeted therapy; immunotherapy; directed protein evolution
10/25/2007US20070248602 Fc Variants Having Increased Affinity for FcyRllc
10/25/2007US20070248601 Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
10/25/2007US20070248600 selection of a CHO (chinese hamster ovary) cell that recombinantly produces an Fc region expressed and glycosylated monoclonal antibody comprising human IgG1 or IgG3 heavy chain constant domains; for manufacture of a medicament
10/25/2007US20070248599 Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248597 Methods of decreasing vascular calcification using IL-1 inhibitors
10/25/2007US20070248595 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
10/25/2007US20070248594 Cxcr1 and cxcr2 chemokine antagonists
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248592 Agent for inhibiting proliferation of neural stem cells
10/25/2007US20070248591 Preventive/Therapeutic Drug for Arteriosclerosis
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248582 Lactic Bacteria and Their Use in the Prevention of Diarrhea
10/25/2007US20070248580 Identification and Isolation of Multipotent Cells From Non-Osteochondral Mesenchymal Tissue
10/25/2007US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007US20070248578 Mrna Transfected Antigen Presenting Cells
10/25/2007US20070248573 Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use
10/25/2007US20070248569 Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
10/25/2007US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007US20070248539 AgRM2 antigen
10/25/2007US20070248538 Cytotoxicity mediation of cells evidencing surface expression of CD44
10/25/2007US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007CA2650131A1 Agonist erythropoietin receptor antibodies
10/25/2007CA2649768A1 Use of trap protein per se as an active ingredient for the manufacture of a medicament for the treatment of staphylococcus aureus infection
10/25/2007CA2649710A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
10/25/2007CA2649661A1 Influenza virus vaccine
10/25/2007CA2649440A1 Methods of treating autoimmune diseases
10/25/2007CA2649431A1 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family and their use for intracellular vectorization and vaccination
10/25/2007CA2649384A1 Erythropoietin receptor agonists
10/25/2007CA2649351A1 Compositions and methods for controlling a honey bee parasitic mite
10/25/2007CA2649326A1 Targeted binding agents directed to upar and uses thereof
10/25/2007CA2649269A1 Protein complex and process for producing the same
10/25/2007CA2649013A1 Her-2/neu multi-peptide vaccine
10/25/2007CA2648223A1 Use of il-i antibodies for treating ophthalmic disorders
10/25/2007CA2647506A1 Concentrate of chikungunya-specific immunoglobulins as medicine
10/25/2007CA2647504A1 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine
10/25/2007CA2646620A1 Therapeutic agent for rheumatoid arthritis
10/25/2007CA2645766A1 Immunogenic wt-1 peptides and methods of use thereof
10/25/2007CA2645365A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains
10/25/2007CA2636129A1 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
10/25/2007CA2635269A1 Adipogenic adenoviruses as a biomarker for disease
10/25/2007CA2613453A1 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
10/24/2007EP1847609A1 BASB205 polypeptides and polynucleotides coding therefor
10/24/2007EP1847602A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES
10/24/2007EP1847593A1 Method for the purification, recovery, and sporulation of cysts and oocysts
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847549A2 Papillomavirus polyprotein constructs
10/24/2007EP1847273A1 April receptor (BCMA) and uses thereof
10/24/2007EP1846767A2 Kid31 and antibodies that bind thereto
10/24/2007EP1846558A2 Inhibiting her2 shedding with matrix metalloprotease antagonists
10/24/2007EP1846556A1 Cloning of honey bee allergen
10/24/2007EP1846550A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition
10/24/2007EP1846455A2 Antibodies to oncostatin m receptor
10/24/2007EP1846453A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes
10/24/2007EP1846452A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 )
10/24/2007EP1846450A2 Antibodies that bind to epha2 and methods of use thereof
10/24/2007EP1846449A2 Irta-2 antibodies and their uses
10/24/2007EP1846432A1 Method for making targeted therapeutic agents
10/24/2007EP1846038A2 Conjugation of streptococcal capsular saccharides
10/24/2007EP1846034A2 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
10/24/2007EP1846033A2 Blockade of elr+cxc chemokines as a treatment for inflammatory and autoimmune disease
10/24/2007EP1846032A2 Luca2 and antibodies that bind thereto
10/24/2007EP1846031A1 Synergistic combination of xolair/omalizumab/e25 with immunosuppressive agent
10/24/2007EP1846030A1 Fixed dosing of her antibodies
10/24/2007EP1846029A2 Vaccination adjuvants pam3cys, poly(i:c), imiquimod, loxoribine, r-848 and cpg-dna together with mhc i or mhc ii epitopes
10/24/2007EP1846028A2 Delivery vehicles, bioactive substances and viral vaccines
10/24/2007EP1846027A2 Improved vaccine against feline calicivirus
10/24/2007EP1846026A2 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
10/24/2007EP1846025A2 Glycoconjugate vaccines containing peptidoglycan
10/24/2007EP1846024A2 Mycobacterial mutants affecting host apoptosis
10/24/2007EP1846023A2 A plasmodium vivax hybrid circumsporozoite protein and vaccine
10/24/2007EP1845974A1 Pharmaceutical compounds
10/24/2007EP1845973A1 Pharmaceutical compounds
10/24/2007EP1383556B1 INJECTION DEVICE FOR ADMINISTERING mRNA
10/24/2007EP1233982B1 Novel hcv non-structural polypeptide
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101061140A Compositions monovalent for CD40L binding and methods of use
10/24/2007CN101061139A Binding member towards pneumolysin
10/24/2007CN101060859A Refrigerator-temperature stable influenza vaccine compositions
10/24/2007CN101060858A Method for determining dosage of oral inactivation vaccine
10/24/2007CN101060776A Methods of studying tolerance in mhc-ii transgenic animals
10/24/2007CN101058800A Animal protein free media for cultivation of cells
10/24/2007CN101058609A Human antibody and expression thereof
10/24/2007CN101058608A Human anti-Abeta(1-32) amyloid antibody, purifying method and use thereof
10/24/2007CN101058607A Anti-helicobacter pylori thallus, cell toxin egg yolk antibody product, preparation and application thereof
10/24/2007CN101057976A Substances for preventing and treating autoimmune diseases
10/24/2007CN101057975A Cocktail vaccine for anti immune tolerance and immunodeficiency virus and its application
10/24/2007CN101057971A Medicine for controlling livestock-poultry virus infectious disease
10/24/2007CN101057970A Therapeutic vaccine for Myostatin specific antibody and its preparation method
1 ... 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 ... 1823